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RESULTS  
METHODS 
We previously showed that Obstructive sleep apnea (OSA), a common public 
health concern causing deleterious cardiometabolic dysfunction, induces 
alterations in red blood cell (RBC) proteome, including redox/oligomeric state 
of PRDX2 as putative biomarker for OSA severity and/or PAP (positive air 
pressure) therapy monitoring (1-3) (Figure 1). Herein, we aimed to investigate 
whether OSA patients with Type 2 Diabetes Mellitus before and after positive 
airway pressure (PAP) treatment present similar changes in the RBC 
antioxidant protein PRDX2 to better understand the molecular basic 
mechanisms associated with OSA and OSA outcomes. 
RBC samples from Snorers (n=22 being 3 diabetics) and OSA patients before and after six month of 
PAP-treatment (n=29 being 8 diabetics) were analysed by non-reducing western blot using antibody 
against PRDX2 or PRDXSO2/3 to measure the total and overoxidized levels of 
monomeric/dimeric/multimeric forms of PRDX2. Groups were statistically compared and correlated 
with clinical/biochemical data and significance set up at 5% (p value< 0.05).  
The redox/oligomeric state of RBC PRDX2 regulated by 
overoxidation of the active cysteines were differentially 
modulated in diabetic OSA patients compared to OSA without 
this comorbidity. PAP-induced overoxidized oligo forms of 
PRDX2 associated with chaperone protective function showed 
decreased in OSA patients with diabetes. 
The clinical impact of all these findings needs further 
investigation and validation.  
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We confirmed our previously data showing higher overoxidation on monomeric forms of PRDX2 in 
OSA RBC that after PAP treatment decreased followed by an increase of multimeric-overoxidized 
forms associated with chaperone protective function (Figure 2B, Figure 3B). In contrast, in diabetic 
OSA RBC, although the level of monomeric PRDX2 was significantly higher abundant compared with 
OSA RBC without this comorbidity (Figure 2A), its levels of overoxidation was significantly lower 
(Figure 2B). After PAP treatment, the level of monomeric PRDX2 decreased but not its overoxidation 
level in diabetic OSA RBC cells (Figure 2A, 2B). The level of oxidized (S-S/S-S) and overoxidized 
(SO3) dimer forms were lower in diabetic OSA RBC compared with OSA RBC without this comorbidity 
(Figure 2C, 2E). After treatment, the level of overoxidation in these dimers decreased in OSA RBC 
without comorbidity but not in diabetic OSA RBC (Figure 2E).  
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The level of PAP-induced PRDX2-overoxidized-multimers was lower in these diabetic OSA RBC 
compared with OSA without comorbidity (Figure 3A,3B).The level of overoxidized monomeric/dimeric 
forms of PRDX2 correlated negatively with levels of insulin / triglycerides and HbA1C, respectively. 
After PAP, the level of (overoxidized) PRDX2SO2/3 multimers correlated positively with adrenaline 
levels(Table) 
Table 
PRDX2
Steady State T6
Monomer EPW (0,464*) 0,013
S-S Dimer Triglycerides (-0,477*) 0,01
S-S/SO2/3 Dimer Dopamin (0,418*) 0,027
SO2/3 Multimer Adrenalin (o,670**) 0,00E+00
Spearman r Value p Value Pearson value p ValueCorrelate
OSA N=29
